Helius Medical Technologies Stock Net Income
| HSDT Stock | USD 0.40 0.01 2.44% |
Helius Medical Technologies fundamentals help investors to digest information that contributes to Helius Medical's financial success or failures. It also enables traders to predict the movement of Helius Stock. The fundamental analysis module provides a way to measure Helius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Helius Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -8 M | -8.4 M | |
| Net Loss | -11.4 M | -12 M | |
| Net Loss | -12.7 M | -13.3 M | |
| Net Loss | (13.10) | (13.76) | |
| Net Income Per E B T | 0.80 | 0.49 |
Helius | Net Income |
Helius Medical Technologies Company Net Income Analysis
Helius Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Helius Medical Net Income | (8.85 M) |
Most of Helius Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Helius Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Helius Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Helius Medical is extremely important. It helps to project a fair market value of Helius Stock properly, considering its historical fundamentals such as Net Income. Since Helius Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Helius Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Helius Medical's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Helius Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Helius Medical Technologies reported net income of (8.85 Million). This is 102.59% lower than that of the Health Care Equipment & Supplies sector and 103.72% lower than that of the Health Care industry. The net income for all United States stocks is 101.55% higher than that of the company.
Helius Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Helius Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics of similar companies.Helius Medical is currently under evaluation in net income category among its peers.
Helius Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Helius Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Helius Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Helius Medical's value.| Shares | Corecap Advisors, Llc | 2024-12-31 | 200 | Fedenia Advisers Llc | 2024-12-31 | 100.0 | Advisor Group Holdings, Inc. | 2024-12-31 | 80.0 | Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 32.0 | Bank Of America Corp | 2024-12-31 | 31.0 | St Germain D J Co Inc | 2024-12-31 | 2.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | The Toronto-dominion Bank | 2024-09-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | Virtu Financial Llc | 2024-12-31 | 46.5 K | Grant Private Wealth Management Inc | 2024-12-31 | 37.2 K |
Helius Fundamentals
| Return On Equity | -2.6 | ||||
| Return On Asset | -1.13 | ||||
| Operating Margin | (79.80) % | ||||
| Current Valuation | (1.18 M) | ||||
| Shares Outstanding | 5.67 M | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 6.63 % | ||||
| Number Of Shares Shorted | 55.52 K | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 0.60 X | ||||
| Price To Sales | 4.48 X | ||||
| Revenue | 644 K | ||||
| Gross Profit | (16 K) | ||||
| EBITDA | (12.11 M) | ||||
| Net Income | (8.85 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 57 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (10.42 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (4.27) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 2.25 M | ||||
| Total Asset | 7.69 M | ||||
| Retained Earnings | (159.96 M) | ||||
| Working Capital | 5.56 M | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
| Net Asset | 7.69 M |
About Helius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Helius Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.